Poplar Therapeutics Funding: $95M Raised, Series A (2026)
Poplar Therapeutics is based in Boston. It has raised $95M in total funding. Latest round: Series A. Backed by SR One, Vida Ventures, Platanus.
Poplar Therapeutics funding overview
Poplar Therapeutics is based in Boston. Poplar Therapeutics has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2026. The round record for Poplar Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include SR One, Vida Ventures, Platanus, Janus Henderson Investors, RA Capital, Arrowmark Partners. 6 distinct backers are named across the disclosed rounds.
Poplar Therapeutics at a glance
Total raised
$95M
Latest round
Series A
Latest round date
March 2026
Headquarters
Boston
Notable investors
SR One, Vida Ventures, Platanus, Janus Henderson Investors, RA Capital, Arrowmark Partners
Frequently asked about Poplar Therapeutics funding
How much has Poplar Therapeutics raised?
Poplar Therapeutics has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Poplar Therapeutics?
SR One, Vida Ventures, Platanus, Janus Henderson Investors, RA Capital, Arrowmark Partners are named among the investors backing Poplar Therapeutics.
What was the latest Poplar Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2026.
Where is Poplar Therapeutics based?
Poplar Therapeutics is based in Boston.
When did Poplar Therapeutics last raise?
The last disclosed Poplar Therapeutics round closed in March 2026 at Series A.
Poplar Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
